However, as a key molecule in tumor angiogenesis VEGF has been shown to be associated with tumor growth and adverse tumor outcomes in ovarian cancer,23, 24 with the anti‐angiogenetic medication bevacizumab, which binds to circulating VEGF, used to treat advanced ovarian cancer.43 The gene discussed is VEGFA; the disease is ovarian carcinoma.